What Researchers Did
Researchers conducted a clinical trial with 39 patients who had insulin-dependent diabetes mellitus (Type 1 diabetes) to evaluate the effectiveness of repeated hyperbaric oxygenation (HBO) courses compared to a control group of 8 patients receiving no treatment.
What They Found
The study found that repeated courses of hyperbaric oxygenation over a year were more effective than a single course in improving diabetes control, reducing insulin use, and restoring some natural insulin production. Specifically, three HBO courses given at four-month intervals showed greater benefits than two courses given six months apart. The most significant positive impact on hormone and metabolic levels was observed during the second course, with the third course helping to maintain these improvements.
What This Means for Canadian Patients
For Canadian patients with Type 1 diabetes, this older research suggests that multiple courses of hyperbaric oxygen therapy might offer benefits for managing blood sugar and reducing insulin needs. However, Type 1 diabetes is not currently a Health Canada-approved condition for HBOT, meaning access to this therapy for diabetes management would likely be outside standard care and not covered by public health insurance.
Canadian Relevance
No direct Canadian connection identified. Type 1 diabetes is not a Health Canada-recognized indication for hyperbaric oxygen therapy.
Study Limitations
This study was limited by its small sample size, the absence of specific hyperbaric oxygenation treatment protocols (like pressure or duration per session), and its age, being published in 1994.